Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSJG-009 Phase II study in denture-induced oral mucosal inflammation
jRCT2031250699Phase 2Recruiting
- Sponsor
- Sunstar
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of SSJG-009 in stomatitis (3 arms), sponsored by Sunstar. Primary endpoint: Change in NRS pain score from baseline. Started Feb 2026; status: recruiting.
02
Drugs
SSJG-009
03
Conditions
stomatitis
Beyond the preview
Go deeper on jRCT2031250699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250699.